● The company has solid fundamentals for a short-term investment strategy.
Strengths
● The stock, which is currently worth 2021 to 0.76 times its sales, is clearly overvalued in comparison with peers.
●
● For the past twelve months, EPS forecast has been revised upwards.
● Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses
● According to forecast, a sluggish sales growth is expected for the next fiscal years.
●
● The company sustains low margins.
● The firm trades with high earnings multiples: 32.15 times its 2021 earnings per share.
● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
● Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.